SCHEMBL9873660

SCHEMBL9873660

CC(C)c1nc2c(OCc3ccccc3)nnc(OCc3ccccc3)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3A Q14432 3/20 0.35
PDE4A P27815 2/20 0.35
PDE4B Q07343 2/20 0.35
PDE4C Q08493 2/20 0.35
PDE4D Q08499 2/20 0.35
PDE3B Q13370 2/20 0.35
AGTR1 P30556 4/20 0.34
AGTR2 P50052 4/20 0.34
ABCB11 O95342 1/20 0.33
EGFR P00533 1/20 0.33
ERBB2 P04626 1/20 0.33
CYP3A4 P08684 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
CYP2C9 P11712 1/20 0.33
ADRB3 P13945 1/20 0.33
ADRA2B P18089 1/20 0.33
SLC6A2 P23975 1/20 0.33
TBXAS1 P24557 1/20 0.33
HTR2C P28335 1/20 0.33
PPARG P37231 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9873245 0.93 AGTR1 (0.34) PDE3APDE4APDE4BPDE4CPDE4D
SCHEMBL9874555 0.91 AGTR1 (0.37) PDE3AAGTR1AGTR2ABCB11EGFR
SCHEMBL9873542 0.90 USP1 (0.33) PDE3AAGTR1AGTR2ABCB11EGFR
SCHEMBL9874827 0.89 AGTR1 (0.37) PDE3APDE4APDE4BPDE4CPDE4D
SCHEMBL9872232 0.88 AGTR1 (0.33) PDE3AAGTR1AGTR2ABCB11EGFR
SCHEMBL9872584 0.88 TP53 (0.35) AGTR1AGTR2PPARG
SCHEMBL9874218 0.87 AGTR1 (0.34) AGTR1AGTR2
SCHEMBL9873966 0.85 AGTR1 (0.33) AGTR1AGTR2PPARG
SCHEMBL9872149 0.85 AGTR1 (0.36) PDE3APDE4APDE4BPDE4CPDE4D
SCHEMBL9873410 0.84 AGTR1 (0.50) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1991019715-A1 1H-SUBSTITUTED-IMIDAZO[4,5-d]PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-12-26 WO disclosed